This issue of Surgical Clinics of North America focuses on The Pancreas Revisited, and is edited by Dr. Avram Cooperman. Articles will include: Is preclinical diagnosis / or prevention of cancer of the pancreas be possible?; Preoperative evaluation of a pancreas mass: diagnostic options; Clinical evaluation of a pancreatic mass: what is essential and practical from a therapeutic standpoint?; Screening of patients at risk for familial pancreatic cancer— what is beneficial?; Incidental IPMN, cystic /premalignant lesions of the pancreas: the case for selective, conservative management; Preoperative stenting for benign and malignant periampullary cancer: the case for selective application; Preoperative stenting for benign and malignant periampullary diseases: unnecessary if not harmful?; Timing of pancreatic resection and patient outcomes: is there a difference?; Outcome analysis for pancreatic surgery: actual vs actuarial methods?; The role of radiation in pancreatic cancer: the European and American view; Adjuvant or neoadjuvant therapy in the treatment in pancreatic malignancies: Where are we?; Nonoperative Ablation of Pancreatic Neoplasms; Incidental IPMN, cystic/ premalignant lesions of the pancreas: The case for aggressive management; Ex Vivo surgery for low grade tumors involving celiac and superior mesenteric arteries; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Foreword - p. xiii 8. Preface - p. xvii 9. Prevention and Early Detection of Pancreatic Cancer - p. 1 10. Preoperative Evaluation of a Pancreas Mass: Diagnostic Options - p. 13 11. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? - p. 25 12. Preoperative Stenting for Benign and Malignant Periampullary Diseases: Unnecessary if Not Harmful - p. 37 13. A Tale of 2 Techniques: Preoperative Biliary Drainage and Routine Surgical Drainage with Pancreaticoduodenectomy - p. 49 14. Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference? - p. 57 15. Cancer of the Pancreas—Actual 5, 10, and 20+Year Survival: The Lucky and Fortunate Few - p. 73 16. Rare, Uncommon, and Unusual Complications After Pancreaticoduodenal Resection - p. 87 17. Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies: Where Are We? - p. 95 18. The Evolving Role of Radiation in Pancreatic Cancer - p. 113 19. Nonoperative Ablation of Pancreatic Neoplasms - p. 127 20. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management - p. 141 21. Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors: Who, When, and How to Treat? - p. 157 22. Rare Tumors and Lesions of the Pancreas - p. 169 23. Ex Vivo Resection and Autotransplantation for Pancreatic Neoplasms - p. 189
This issue of Surgical Clinics of North America focuses on The Pancreas Revisited, and is edited by Dr. Avram Cooperman. Articles will include: Is preclinical diagnosis / or prevention of cancer of the pancreas be possible?; Preoperative evaluation of a pancreas mass: diagnostic options; Clinical evaluation of a pancreatic mass: what is essential and practical from a therapeutic standpoint?; Screening of patients at risk for familial pancreatic cancer— what is beneficial?; Incidental IPMN, cystic /premalignant lesions of the pancreas: the case for selective, conservative management; Preoperative stenting for benign and malignant periampullary cancer: the case for selective application; Preoperative stenting for benign and malignant periampullary diseases: unnecessary if not harmful?; Timing of pancreatic resection and patient outcomes: is there a difference?; Outcome analysis for pancreatic surgery: actual vs actuarial methods?; The role of radiation in pancreatic cancer: the European and American view; Adjuvant or neoadjuvant therapy in the treatment in pancreatic malignancies: Where are we?; Nonoperative Ablation of Pancreatic Neoplasms; Incidental IPMN, cystic/ premalignant lesions of the pancreas: The case for aggressive management; Ex Vivo surgery for low grade tumors involving celiac and superior mesenteric arteries; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Foreword - p. xiii 8. Preface - p. xvii 9. Prevention and Early Detection of Pancreatic Cancer - p. 1 10. Preoperative Evaluation of a Pancreas Mass: Diagnostic Options - p. 13 11. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? - p. 25 12. Preoperative Stenting for Benign and Malignant Periampullary Diseases: Unnecessary if Not Harmful - p. 37 13. A Tale of 2 Techniques: Preoperative Biliary Drainage and Routine Surgical Drainage with Pancreaticoduodenectomy - p. 49 14. Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference? - p. 57 15. Cancer of the Pancreas—Actual 5, 10, and 20+Year Survival: The Lucky and Fortunate Few - p. 73 16. Rare, Uncommon, and Unusual Complications After Pancreaticoduodenal Resection - p. 87 17. Adjuvant or Neoadjuvant Therapy in the Treatment in Pancreatic Malignancies: Where Are We? - p. 95 18. The Evolving Role of Radiation in Pancreatic Cancer - p. 113 19. Nonoperative Ablation of Pancreatic Neoplasms - p. 127 20. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management - p. 141 21. Nonfunctioning Incidental Pancreatic Neuroendocrine Tumors: Who, When, and How to Treat? - p. 157 22. Rare Tumors and Lesions of the Pancreas - p. 169 23. Ex Vivo Resection and Autotransplantation for Pancreatic Neoplasms - p. 189
